Arthur Tzianabos - Insider Trading & Ownership

Entity
Individual
Location
C/O Homology Medicines, Inc., One Patriots Park, Bedford, MA
Summary
The estimated net worth of Arthur Tzianabos is at least $434K dollars as of June 7, 2024. Arthur Tzianabos is the Director of Q32 Bio Inc. and owns shares of Q32 Bio Inc. (QTTB) stock worth about $365K. Arthur Tzianabos is the Director of Stoke Therapeutics, Inc. and owns shares of Stoke Therapeutics, Inc. (STOK) stock worth about $69.5K.
All Insider Reports
All Insider Reports

Ownership of Arthur Tzianabos

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
QTTB Q32 Bio Inc. Director $365K -$13.9K -3.66% Mar 25, 2024
STOK Stoke Therapeutics, Inc. Director $69.5K Jun 5, 2024
AKUS Akouos, Inc. Director Nov 30, 2022

Insider Transactions Reported by Arthur Tzianabos:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.